Asian equity benchmarks are trading in red on Wednesday, as the global shares dipped and crude oil rates plunged after a steep correction in technological shares. Besides, Brexit uncertainty and mounting worries over flare-ups in coronavirus cases also dulled investor sentiments. Meanwhile, reports that, AstraZeneca’s late-stage trial of its Covid-19 vaccine candidate has been put on hold due to safety concerns, also raised risk aversion. Japan's Nikkei is also trading weaker in line with the third straight slide in US stock market, and as the safe-haven yen strengthened. Among the Asian markets, Japan, South Korea, Taiwan, Singapore, Hong Kong China, Indonesia and Malaysia are in downward trend.
Nikkei 225 down by 232.92 points, 1.00% to 23,041.21, Straits Times dipped by 12.97 points 0.52% to 2,491.79, Hang Seng shrunk by 147.39 points or 0.60% to 24,476.95, Taiwan Weighted lowered 87.95 points 0.69% to 12,575.61, KOSPI Index diminished by 15.28 points or 0.64% to 2,386.63, Jakarta Composite decreased by 65.07 points 0r 1.24% to 5,179.00, Shanghai reduced 30.70 points or 0.93% to 3,285.72, FTSE Bursa Malaysia KLCI narrowed by 23.61 points or 1.55% to 1,495.71.
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: